Combined anticoagulant and platelet-antiaggregating therapy in patients with atrial fibrillation;Tratamiento anticoagulante y antiagregante plaquetario combinado en pacientes con fibrilación auricular

Revista Espanola de Cardiologia

Volumn 62, Issue 9, 2009, Pages 972-975

  Lip, Gregory Y H ^a   Lane, Deirdre A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CLOPIDOGREL; DIPYRIDAMOLE; FLUINDIONE; IDRAPARINUX; IRBESARTAN; THROMBIN INHIBITOR; TICLOPIDINE; TRIFLUSAL; WARFARIN; XIMELAGATRAN; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; THROMBOEMBOLISM; DRUG COMBINATION; NOTE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 70349249399     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)72094-9     Document Type: Editorial

References (12)

1. G.Y.H. Lip, and C.J. Boos Antithrombotic treatment in atrial fibrillation Heart 92 2006 155 161 (Pubitemid 43131948)
2. S.J. Connolly, J. Pogue, J. Eikelboom, G. Flaker, P. Commerford, M.G. Franzosi, et al. ACTIVE W Investigators Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range Circulation 118 2008 2029 2037
3. The ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
4. P. Lechat, H. Lardoux, A. Mallet, P. Sánchez, G. Dermeaux, and T. Lecompt Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation: a randomized trial (Fluindione, Fibrillation, Auriculaire, Aspirin et Contraste Spontane; FFAACS) Cerebrovasc Dis 12 2001 245 252 (Pubitemid 32973957)
5. F. Pérez-Gómez, E. Alegría, J. Berjón, J.A. Iriarte, J. Zumalde, A. Salvador NASPEAF Investigators Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study J Am Coll Cardiol 44 2004 1557 1566 (Pubitemid 39377708)
6. M.G. Bousser, J. Bouthier, H.R. Büller, A.T. Cohen, H. Crijns, B.L. Davidson B.L., et al. Amadeus Investigators Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial Lancet 371 2008 315 321
7. G.C. Flaker, M. Gruber, S.J. Connolly, S. Goldman, S. Chapparro, and A. Vahanian Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials Am Heart J 152 2006 967 973 (Pubitemid 44637136)
8. R. Bover, F. Pérez-Gómez, M. Maluenda, S. Asenjo, R. Pérez-Saldaña, and A. Igea, et al. Seguimiento a largo plazo de enfermos con fibrilación auricular del estudio NASPEAF. Control prospectivo de otros tratamientos antiplaquetarios Rev Esp Cardiol 62 2009 992 1000
9. F. Dentali, J.D. Douketis, W. Lim, and M. Crowther Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials Arch Intern Med 167 2007 117 124 (Pubitemid 46148058)
10. T. Schalekamp, O. Klungel, P. Souverein, and A. De Boer Effect of oral antiplatelet agents on major bleeding in users of coumarins Thromb Haemost 100 2008 1076 1083
11. G.Y.H. Lip Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation BMJ 336 2008 614 615
12. A. Rubboli, J.L. Halperin, K.E. Airaksinen, M. Buerke, E. Eeckhout, and S.B. Freedman, et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation Ann Med 40 2008 428 436